Tomislav Kulis

Dr. Tomislav Kulis

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
DCDavid V. Conti
David V. Conti
BDBurcu F. Darst
Burcu F. Darst
LMLilit C. Moss
Lilit C. Moss
ESEdward J. Saunders
Edward J. Saunders
XSXin Sheng
Xin Sheng
CHChristopher A. Haiman
Christopher A. Haiman

9 November 2023 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
AWAnqi Wang
Anqi Wang
JSJiayi Shen
Jiayi Shen
ARAlex A. Rodriguez
Alex A. Rodriguez
ESEdward J. Saunders
Edward J. Saunders
FCFei Chen
Fei Chen
CHChristopher A. Haiman
Christopher A. Haiman

25 April 2021 in Cancers
Verified
Journal Article
Open access
PDF file
IAIrena Abramovic
Irena Abramovic
BVBorna Vrhovec
Borna Vrhovec
LALucija Škara Abramović
Lucija Škara Abramović
AVAlen Vrtarić
Alen Vrtarić
NGNora Nikolac Gabaj
Nora Nikolac Gabaj
NSNino Sincic
Nino Sincic
Prostate cancer (PCa) is the most commonly diagnosed neoplasm among men. Since it often resembles benign prostate hyperplasia (BPH), biomarkers with a higher differential value than PSA are required. Epigenetic biomarkers in liquid biopsies, especially miRNA, could address this challenge. The absolute expression of miR-375-3p, miR-182-5p, miR-21-5p, and miR-148a-3p were quantified in blood plasma and seminal plasma of 65 PCa and 58 BPH patients by digital droplet PCR. The sensitivity and specificity of these microRNAs were determined using ROC curve analysis. The higher expression of miR-182-5p and miR-375-3p in the blood plasma of PCa patients was statistically significant as compared to BPH (p = 0.0363 and 0.0226, respectively). Their combination achieved a specificity of 90.2% for predicting positive or negative biopsy results, while PSA cut-off of 4 µg/L performed with only 1.7% specificity. In seminal plasma, miR-375-3p, miR-182-5p, and miR-21-5p showed a statistically significantly higher expression in PCa patients with PSA >10 µg/L compared to ones with PSA ≤10 µg/L. MiR-182-5p and miR-375-3p in blood plasma show higher performance than PSA in discriminating PCa from BPH. Seminal plasma requires further investigation as it represents an obvious source for PCa biomarker identification.

1 December 2019 in Croatian Medical Journal
Verified
Journal Article
Open access
ŽKŽeljko Kaštelan
Željko Kaštelan
NKNikola Knežević
Nikola Knežević
THTvrtko Hudolin
Tvrtko Hudolin
TKTomislav Kulis
Tomislav Kulis
LPLuka Penezić
Luka Penezić
AĆAnte Ćorušić
Ante Ćorušić

1 December 2020 in European Urology
Verified
Journal Article
Closed access
ZKZeljko Kastelan
Zeljko Kastelan
THTvrtko Hudolin
Tvrtko Hudolin
TKTomislav Kulis
Tomislav Kulis
LPLuka Penezic
Luka Penezic
SGStefano Gidaro
Stefano Gidaro
NKNikola Knezevic
Nikola Knezevic

18 October 2021 in The International Journal of Medical Robotics and Computer Assisted Surgery
Verified
Journal Article
Closed access
PDF file
TKTomislav Kulis
Tomislav Kulis
THTvrtko Hudolin
Tvrtko Hudolin
LPLuka Penezić
Luka Penezić
TZToni Zekulić
Toni Zekulić
HSHrvoje Saic
Hrvoje Saic
ZKZeljko Kastelan
Zeljko Kastelan